Plan Outline
Get real P&L data for your plan!
We have complete profit and loss financial data from companies like The Medical Group.
SIC 8011 Health Services - Offices and clinics of medical doctors
*Reports start as low as $89
Medical Services Management Business Plan
The Medical Group
This sample business plan can be edited directly in Business Plan Pro software.
Financial Plan
The company is raising funding to complete development through Year 2 of operation.
8.1 Important Assumptions
The following table presents some assumptions that are necessary to the success of TMG.
| General Assumptions | |||
| Year 1 | Year 2 | Year 3 | |
| Plan Month | 1 | 2 | 3 |
| Current Interest Rate | 10.00% | 10.00% | 10.00% |
| Long-term Interest Rate | 10.00% | 10.00% | 10.00% |
| Tax Rate | 25.42% | 25.00% | 25.42% |
| Other | 0 | 0 | 0 |
8.2 Break-even Analysis
The chart and table below outline present the Break-even Analysis for TMG.
| Break-even Analysis | |
| Monthly Revenue Break-even | $69,700 |
| Assumptions: | |
| Average Percent Variable Cost | 9% |
| Estimated Monthly Fixed Cost | $63,217 |
8.3 Projected Profit and Loss
The company is in the early stage of development, thus initial projections have only been made on accounts that are believed to most drive the income statement.
| Pro Forma Profit and Loss | |||
| Year 1 | Year 2 | Year 3 | |
| Sales | $1,075,000 | $16,125,000 | $45,125,000 |
| Direct Cost of Sales | $100,000 | $1,500,000 | $3,000,000 |
| Other | $38,000 | $570,000 | $600,000 |
| Total Cost of Sales | $138,000 | $2,070,000 | $3,600,000 |
| Gross Margin | $937,000 | $14,055,000 | $41,525,000 |
| Gross Margin % | 87.16% | 87.16% | 92.02% |
| Expenses | |||
| Payroll | $256,522 | $453,066 | $608,696 |
| Sales and Marketing and Other Expenses | $382,000 | $2,163,810 | $3,366,850 |
| Depreciation | $8,400 | $0 | $0 |
| Continued education | $36,000 | $517,500 | $575,500 |
| Utilities | $3,600 | $4,000 | $4,500 |
| Insurance | $9,600 | $20,000 | $25,000 |
| Rent | $24,000 | $25,000 | $25,000 |
| Payroll Taxes | $38,478 | $67,960 | $91,304 |
| Other | $0 | $0 | $0 |
| Total Operating Expenses | $758,600 | $3,251,336 | $4,696,850 |
| Profit Before Interest and Taxes | $178,400 | $10,803,664 | $36,828,150 |
| EBITDA | $186,800 | $10,803,664 | $36,828,150 |
| Interest Expense | $0 | $0 | $0 |
| Taxes Incurred | $42,564 | $2,700,916 | $9,360,488 |
| Net Profit | $135,835 | $8,102,748 | $27,467,662 |
| Net Profit/Sales | 12.64% | 50.25% | 60.87% |
8.4 Projected Cash Flow
The cash flow projections are presented in the following chart and table.
| Pro Forma Cash Flow | |||
| Year 1 | Year 2 | Year 3 | |
| Cash Received | |||
| Cash from Operations | |||
| Cash Sales | $0 | $0 | $0 |
| Cash from Receivables | $868,500 | $13,234,000 | $39,554,302 |
| Subtotal Cash from Operations | $868,500 | $13,234,000 | $39,554,302 |
| Additional Cash Received | |||
| Sales Tax, VAT, HST/GST Received | $0 | $0 | $0 |
| New Current Borrowing | $0 | $0 | $0 |
| New Other Liabilities (interest-free) | $0 | $0 | $0 |
| New Long-term Liabilities | $0 | $0 | $0 |
| Sales of Other Current Assets | $0 | $0 | $0 |
| Sales of Long-term Assets | $0 | $0 | $0 |
| New Investment Received | $500,000 | $0 | $0 |
| Subtotal Cash Received | $1,368,500 | $13,234,000 | $39,554,302 |
| Expenditures | Year 1 | Year 2 | Year 3 |
| Expenditures from Operations | |||
| Cash Spending | $256,522 | $453,066 | $608,696 |
| Bill Payments | $616,643 | $7,004,661 | $16,269,509 |
| Subtotal Spent on Operations | $873,165 | $7,457,727 | $16,878,205 |
| Additional Cash Spent | |||
| Sales Tax, VAT, HST/GST Paid Out | $0 | $0 | $0 |
| Principal Repayment of Current Borrowing | $0 | $0 | $0 |
| Other Liabilities Principal Repayment | $0 | $0 | $0 |
| Long-term Liabilities Principal Repayment | $0 | $0 | $0 |
| Purchase Other Current Assets | $0 | $0 | $0 |
| Purchase Long-term Assets | $500,000 | $2,000,000 | $8,000,000 |
| Dividends | $0 | $0 | $0 |
| Subtotal Cash Spent | $1,373,165 | $9,457,727 | $24,878,205 |
| Net Cash Flow | ($4,665) | $3,776,273 | $14,676,097 |
| Cash Balance | $245,335 | $4,021,608 | $18,697,706 |
8.5 Projected Balance Sheet
The table below provides TMG's projected balance sheet for 2000-2002.
| Pro Forma Balance Sheet | |||
| Year 1 | Year 2 | Year 3 | |
| Assets | |||
| Current Assets | |||
| Cash | $245,335 | $4,021,608 | $18,697,706 |
| Accounts Receivable | $206,500 | $3,097,500 | $8,668,198 |
| Other Current Assets | $5,000 | $5,000 | $5,000 |
| Total Current Assets | $456,835 | $7,124,108 | $27,370,903 |
| Long-term Assets | |||
| Long-term Assets | $500,000 | $2,500,000 | $10,500,000 |
| Accumulated Depreciation | $8,400 | $8,400 | $8,400 |
| Total Long-term Assets | $491,600 | $2,491,600 | $10,491,600 |
| Total Assets | $948,435 | $9,615,708 | $37,862,503 |
| Liabilities and Capital | Year 1 | Year 2 | Year 3 |
| Current Liabilities | |||
| Accounts Payable | $57,599 | $622,125 | $1,401,258 |
| Current Borrowing | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 |
| Subtotal Current Liabilities | $57,599 | $622,125 | $1,401,258 |
| Long-term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $57,599 | $622,125 | $1,401,258 |
| Paid-in Capital | $850,000 | $850,000 | $850,000 |
| Retained Earnings | ($95,000) | $40,835 | $8,143,584 |
| Earnings | $135,835 | $8,102,748 | $27,467,662 |
| Total Capital | $890,835 | $8,993,584 | $36,461,245 |
| Total Liabilities and Capital | $948,435 | $9,615,708 | $37,862,503 |
| Net Worth | $890,835 | $8,993,584 | $36,461,245 |
8.6 Business Ratios
The following table contains important business ratios for the offices and clinics of medical doctors industry, as determined by the Standard Industry Classification (SIC) Index code 8011, Offices & Clinics of Medical Doctors.
| Ratio Analysis | ||||
| Year 1 | Year 2 | Year 3 | Industry Profile | |
| Sales Growth | 0.00% | 1400.00% | 179.84% | 5.90% |
| Percent of Total Assets | ||||
| Accounts Receivable | 21.77% | 32.21% | 22.89% | 10.00% |
| Other Current Assets | 0.53% | 0.05% | 0.01% | 50.50% |
| Total Current Assets | 48.17% | 74.09% | 72.29% | 60.80% |
| Long-term Assets | 51.83% | 25.91% | 27.71% | 39.20% |
| Total Assets | 100.00% | 100.00% | 100.00% | 100.00% |
| Current Liabilities | 6.07% | 6.47% | 3.70% | 39.80% |
| Long-term Liabilities | 0.00% | 0.00% | 0.00% | 14.10% |
| Total Liabilities | 6.07% | 6.47% | 3.70% | 53.90% |
| Net Worth | 93.93% | 93.53% | 96.30% | 46.10% |
| Percent of Sales | ||||
| Sales | 100.00% | 100.00% | 100.00% | 100.00% |
| Gross Margin | 87.16% | 87.16% | 92.02% | 0.00% |
| Selling, General & Administrative Expenses | 74.72% | 36.91% | 30.81% | 57.10% |
| Advertising Expenses | 6.14% | 6.05% | 2.77% | 0.40% |
| Profit Before Interest and Taxes | 16.60% | 67.00% | 81.61% | 2.00% |
| Main Ratios | ||||
| Current | 7.93 | 11.45 | 19.53 | 1.37 |
| Quick | 7.93 | 11.45 | 19.53 | 1.12 |
| Total Debt to Total Assets | 6.07% | 6.47% | 3.70% | 53.90% |
| Pre-tax Return on Net Worth | 20.03% | 120.13% | 101.01% | 6.90% |
| Pre-tax Return on Assets | 18.81% | 112.35% | 97.27% | 15.00% |
| Additional Ratios | Year 1 | Year 2 | Year 3 | |
| Net Profit Margin | 12.64% | 50.25% | 60.87% | n.a |
| Return on Equity | 15.25% | 90.09% | 75.33% | n.a |
| Activity Ratios | ||||
| Accounts Receivable Turnover | 5.21 | 5.21 | 5.21 | n.a |
| Collection Days | 57 | 37 | 48 | n.a |
| Accounts Payable Turnover | 11.71 | 12.17 | 12.17 | n.a |
| Payment Days | 27 | 16 | 22 | n.a |
| Total Asset Turnover | 1.13 | 1.68 | 1.19 | n.a |
| Debt Ratios | ||||
| Debt to Net Worth | 0.06 | 0.07 | 0.04 | n.a |
| Current Liab. to Liab. | 1.00 | 1.00 | 1.00 | n.a |
| Liquidity Ratios | ||||
| Net Working Capital | $399,235 | $6,501,984 | $25,969,645 | n.a |
| Interest Coverage | 0.00 | 0.00 | 0.00 | n.a |
| Additional Ratios | ||||
| Assets to Sales | 0.88 | 0.60 | 0.84 | n.a |
| Current Debt/Total Assets | 6% | 6% | 4% | n.a |
| Acid Test | 4.35 | 6.47 | 13.35 | n.a |
| Sales/Net Worth | 1.21 | 1.79 | 1.24 | n.a |
| Dividend Payout | 0.00 | 0.00 | 0.00 | n.a |
